MYGN - Myriad Genetics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$2.90
DETAILS
HIGH:
$3.60
LOW:
$2.00
MEDIAN:
$3.00
CONSENSUS:
$2.90
DOWNSIDE:
15.20%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: MYGN has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.